Innovative Clinical Trial Enhances Detection of Hidden Blood Clots in Stroke Patients
A new clinical trial demonstrates that enhanced CT imaging including the heart greatly improves detection of blood clots in stroke patients, leading to better targeted treatments and stroke prevention.
A groundbreaking clinical trial conducted by the London Health Sciences Centre Research Institute (LHSCRI) in collaboration with Western University's Schulich School of Medicine & Dentistry has demonstrated a significant advancement in identifying concealed blood clots responsible for strokes. Published in The Lancet Neurology, this study highlights that extending computed tomography (CT) imaging to include the heart shortly after a patient's hospital arrival markedly improves the detection of cardiac-origin blood clots, which are a leading cause of ischemic strokes.
Strokes caused by blood clots, or other blockages obstructing blood flow in the brain, account for approximately 85% of all stroke cases. Traditionally, standard imaging focuses on the brain, often leaving the source of the clot undetermined. The new approach involves a modified CT scan that includes detailed images of the heart and aorta, allowing clinicians to identify the origin of clots with much higher accuracy.
Dr. Luciano Sposato, a senior scientist at LHSCRI and a professor of neurology, emphasizes the importance of accurately locating the clot source: "Knowing whether the clot originated in the heart guides us toward the most effective treatment, such as blood thinners to prevent future strokes." The trial involved 465 patients admitted with acute stroke or transient ischemic attack at LHSC's University Hospital. The findings revealed that the extended CT scan increased the detection rate of cardiac blood clots by 600%, without delaying emergency imaging procedures. Interestingly, the technique identified one clot for every 14 patients scanned, demonstrating its efficiency.
Furthermore, Dr. Rodrigo Bagur, a researcher at LHSCRI and a cardiologist, highlighted the clinical impact: "Without extending the CT, many of these blood clots would remain undetected, leading to strokes with unknown causes. This new imaging method allows for better-targeted treatments, potentially reducing recurrence and improving patient outcomes."
This innovative diagnostic strategy represents a significant step toward personalized stroke management, enabling healthcare providers to accurately identify clot sources and tailor treatments accordingly. Overall, this research underscores the importance of advanced imaging in improving stroke diagnostics and patient care.
source: https://medicalxpress.com/news/2025-06-clinical-trial-significantly-hidden-blood.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Artificial Intelligence Gap Impeding Healthcare Advancements in the Global South
A new study highlights the global disparities in AI adoption in healthcare, emphasizing the challenges faced by the Global South and the need for equitable international collaboration to foster health equity.
Enhancing Prenatal Care to Reduce Low Birth Weight Risks
A new study highlights the critical role of increased prenatal checkups in improving birth weights and reducing low birth weight cases in The Gambia, supporting better neonatal health outcomes.
FDA Approves Simplified Prefilled Syringe Format for Shingles Vaccine
The FDA has approved a new prefilled syringe version of GSK's Shingrix vaccine for shingles prevention, simplifying administration and enhancing healthcare efficiency.
Discovery of a Behavioral Biomarker for Early Detection of Parkinson's Disease in Mice
New research using machine learning uncovers early behavioral signs in mice that could lead to earlier diagnosis of Parkinson's disease, potentially transforming treatment approaches.